ArticleArchives of orthopaedic and trauma surgery2025
Viability of chondrocytes harvested during treatment of hip femoroacetabular impingement.
Article in Archives of orthopaedic and trauma surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to collect tissue overlying a CAM deformity for subsequent cell culture and chondrocyte expression as a proof of concept of clinical feasibility for autologous cell-based cartilage restoration in the hip.
methodsIRB approval was obtained to collect otherwise-discarded tissues from patients undergoing surgical management of labral tears and FAI. The collected tissue was exposed to collagenase type II for 16-24 h for chondrocyte isolation. Isolated cells were counted and seeded onto T-25 flasks in DMEM supplemented with 10% FBS. Media was changed every three days until > 90% confluency. At confluency, cells were counted and seeded onto a T-175 flask representing passage one. At second confluency, cells were counted again; if the total did not surpass 20,000,000 cells based on the minimum number needed for cell-based treatments, they were seeded onto two T-175 flasks representing passage two. Cells were not expanded beyond passage two based on the goal of phenotype maintenance.
resultsMean weight of collected tissues was 209.69 ± 78.09 mg (median = 202 mg). 41 of 55 samples reached > 20,000,000 cells at a mean of 33.98 ± 13.06 days (median = 30 days). Mean initial cell seeding of successful expansions was 1,116,871.79 ± 2,271,995.77 cells (median = 340,000 cells). Of samples that failed to reach threshold, five did not have sufficient cells following chondrocyte isolation to establish culture, and nine did not progress toward confluency for passage one. There were no significant differences in patient age (p =.988) or sex (p =.537) between successful versus unsuccessful expansions. There was a significant difference in patient BMI (p <.001) between successful versus unsuccessful expansions.
conclusions74.5% of tissue samples reached the minimum threshold (20 million cells), indicating successful expansions that may be sufficient for use in hip preservation procedures involving cell-based cartilage restoration. These findings support the viability of chondrocytes harvested from tissue overlying CAM deformities, and the feasibility of utilizing the tissue in subsequent autologous chondrocyte implantation procedures.
Indexed as
Identifiers
40481851What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.